Skip to main content
Top
Published in: Endocrine 1/2019

01-10-2019 | Thyroiditis | Review

Thyroid hormone therapy in congenital hypothyroidism and pediatric hypothyroidism

Authors: Andrew J. Bauer, Ari J. Wassner

Published in: Endocrine | Issue 1/2019

Login to get access

Abstract

The evaluation and management of hypothyroidism in children are similar to adults, but there are important differences based on the dependence on normal thyroid function for neurocognitive and physical development. In the pediatric population, hypothyroidism is frequently categorized as congenital or acquired hypothyroidism, depending on the age of presentation and the underlying etiology. The evaluation and management of children and adolescents with hypothyroidism are determined by the etiology as well as by the age at diagnosis, severity of the hypothyroidism, and the response to thyroid hormone replacement therapy. Children and adolescents require higher weight-based doses for thyroid hormone replacement than do adults, likely due to a shorter half-life of thyroxine (T4) and triiodothyronine (T3) in children, but weight-based dose requirements decrease as the child advances into adulthood. Multiple gaps in knowledge remains regarding how to optimize the treatment of hypothyroidism in pediatric patients, including (but not limited to) the selection of patients with subclinical hypothyroidism for treatment, and the potential benefit of combined LT3/LT4 therapy for patients with persistent symptoms and/or low T3 on LT4 monotherapy. The life-long impact on growth and development, and potentially on long-term cardiovascular and psychosocial health, are significant and highlight the importance of future prospective studies in pediatric patients to explore these areas of uncertainty.
Literature
5.
go back to reference G. Gunapalasingham, C. Frithioff-Bojsoe, M.A.V. Lund, P.L. Hedley, C.E. Fonvig, M. Dahl, O. Pedersen, M. Christiansen, T. Hansen, U. Lausten-Thomsen, J.C. Holm, Reference values for fasting serum concentrations of thyroid-stimulating hormone and thyroid hormones in healthy Danish/North-European white children and adolescents. Scand. J. Clin. Lab. Investig. 79(1-2), 129–135 (2019). https://doi.org/10.1080/00365513.2019.1581945 CrossRef G. Gunapalasingham, C. Frithioff-Bojsoe, M.A.V. Lund, P.L. Hedley, C.E. Fonvig, M. Dahl, O. Pedersen, M. Christiansen, T. Hansen, U. Lausten-Thomsen, J.C. Holm, Reference values for fasting serum concentrations of thyroid-stimulating hormone and thyroid hormones in healthy Danish/North-European white children and adolescents. Scand. J. Clin. Lab. Investig. 79(1-2), 129–135 (2019). https://​doi.​org/​10.​1080/​00365513.​2019.​1581945 CrossRef
6.
7.
go back to reference J. Simpson, F.L. Williams, C. Delahunty, H. van Toor, S.Y. Wu, S.A. Ogston, T.J. Visser, R. Hume, Scottish Preterm Thyroid, G.: Serum thyroid hormones in preterm infants and relationships to indices of severity of intercurrent illness. J. Clin. Endocrinol. Metab. 90(3), 1271–1279 (2005). https://doi.org/10.1210/jc.2004-2091 CrossRefPubMed J. Simpson, F.L. Williams, C. Delahunty, H. van Toor, S.Y. Wu, S.A. Ogston, T.J. Visser, R. Hume, Scottish Preterm Thyroid, G.: Serum thyroid hormones in preterm infants and relationships to indices of severity of intercurrent illness. J. Clin. Endocrinol. Metab. 90(3), 1271–1279 (2005). https://​doi.​org/​10.​1210/​jc.​2004-2091 CrossRefPubMed
8.
go back to reference F.L. Williams, J. Simpson, C. Delahunty, S.A. Ogston, J.J. Bongers-Schokking, N. Murphy, H. van Toor, S.Y. Wu, T.J. Visser, R. Hume,Collaboration from the Scottish Preterm Thyroid, G, Developmental trends in cord and postpartum serum thyroid hormones in preterm infants. J. Clin. Endocrinol. Metab. 89(11), 5314–5320 (2004). https://doi.org/10.1210/jc.2004-0869 CrossRefPubMed F.L. Williams, J. Simpson, C. Delahunty, S.A. Ogston, J.J. Bongers-Schokking, N. Murphy, H. van Toor, S.Y. Wu, T.J. Visser, R. Hume,Collaboration from the Scottish Preterm Thyroid, G, Developmental trends in cord and postpartum serum thyroid hormones in preterm infants. J. Clin. Endocrinol. Metab. 89(11), 5314–5320 (2004). https://​doi.​org/​10.​1210/​jc.​2004-0869 CrossRefPubMed
9.
go back to reference A.M. Dumitrescu, S. Refetoff, S., in Impaired Sensitivity to Thyroid Hormone: Defects of Transport, Metabolism and Action. ed. by K.R. Feingold, B. Anawalt, A. Boyce, G. Chrousos, K. Dungan, A. Grossman, J.M. Hershman, G. Kaltsas, C. Koch, P. Kopp, M. Korbonits, R. McLachlan, J.E. Morley, M. New, L. Perreault, J. Purnell, R. Rebar, F. Singer, D.L. Trence, A. Vinik, D.P. Wilson (Endotext, South Dartmouth, MA, 2000) A.M. Dumitrescu, S. Refetoff, S., in Impaired Sensitivity to Thyroid Hormone: Defects of Transport, Metabolism and Action. ed. by K.R. Feingold, B. Anawalt, A. Boyce, G. Chrousos, K. Dungan, A. Grossman, J.M. Hershman, G. Kaltsas, C. Koch, P. Kopp, M. Korbonits, R. McLachlan, J.E. Morley, M. New, L. Perreault, J. Purnell, R. Rebar, F. Singer, D.L. Trence, A. Vinik, D.P. Wilson (Endotext, South Dartmouth, MA, 2000)
11.
go back to reference I. Onsesveren, M. Barjaktarovic, L. Chaker, Y.B. de Rijke, V.W.V. Jaddoe, H.M. van Santen, T.J. Visser, R.P. Peeters, T.I.M. Korevaar, Childhood thyroid function reference ranges and determinants: a literature overview and a prospective cohort study. Thyroid. 27(11), 1360–1369 (2017). https://doi.org/10.1089/thy.2017.0262 CrossRefPubMed I. Onsesveren, M. Barjaktarovic, L. Chaker, Y.B. de Rijke, V.W.V. Jaddoe, H.M. van Santen, T.J. Visser, R.P. Peeters, T.I.M. Korevaar, Childhood thyroid function reference ranges and determinants: a literature overview and a prospective cohort study. Thyroid. 27(11), 1360–1369 (2017). https://​doi.​org/​10.​1089/​thy.​2017.​0262 CrossRefPubMed
26.
go back to reference R.S. Brown, C.A. Alter, A. Sadeghi-Nejad, Severe unsuspected maternal hypothyroidism discovered after the diagnosis of thyrotropin receptor-blocking antibody-induced congenital hypothyroidism in the neonate: failure to recognize and implications to the fetus. Horm. Res. Paediatr. 83(2), 132–135 (2015). https://doi.org/10.1159/000368671 CrossRefPubMed R.S. Brown, C.A. Alter, A. Sadeghi-Nejad, Severe unsuspected maternal hypothyroidism discovered after the diagnosis of thyrotropin receptor-blocking antibody-induced congenital hypothyroidism in the neonate: failure to recognize and implications to the fetus. Horm. Res. Paediatr. 83(2), 132–135 (2015). https://​doi.​org/​10.​1159/​000368671 CrossRefPubMed
30.
go back to reference D.A. Fisher, W.D. Odell, C.J. Hobel, R. Garza, Thyroid function in the term fetus. Pediatrics 44(4), 526–535 (1969)PubMed D.A. Fisher, W.D. Odell, C.J. Hobel, R. Garza, Thyroid function in the term fetus. Pediatrics 44(4), 526–535 (1969)PubMed
31.
go back to reference J. Leger, A. Olivieri, M. Donaldson, T. Torresani, H. Krude, G. van Vliet, M. Polak, G. Butler, European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. Horm. Res. Paediatr. 81(2), 80–103 (2014). https://doi.org/10.1159/000358198 CrossRefPubMed J. Leger, A. Olivieri, M. Donaldson, T. Torresani, H. Krude, G. van Vliet, M. Polak, G. Butler, European Society for Paediatric Endocrinology consensus guidelines on screening, diagnosis, and management of congenital hypothyroidism. Horm. Res. Paediatr. 81(2), 80–103 (2014). https://​doi.​org/​10.​1159/​000358198 CrossRefPubMed
32.
go back to reference N. McGrath, C.P. Hawkes, P. Mayne, N.P. Murphy, Permanent decompensated congenital hypothyroidism in newborns with whole-blood thyroid-stimulating hormone concentrations between 8 and 10 mU/L: the case for lowering the threshold. Horm. Res. Paediatr. 89(4), 265–270 (2018). https://doi.org/10.1159/000488288 CrossRefPubMed N. McGrath, C.P. Hawkes, P. Mayne, N.P. Murphy, Permanent decompensated congenital hypothyroidism in newborns with whole-blood thyroid-stimulating hormone concentrations between 8 and 10 mU/L: the case for lowering the threshold. Horm. Res. Paediatr. 89(4), 265–270 (2018). https://​doi.​org/​10.​1159/​000488288 CrossRefPubMed
33.
go back to reference S. Rabbiosi, M.C. Vigone, F. Cortinovis, I. Zamproni, L. Fugazzola, L. Persani, C. Corbetta, G. Chiumello, G. Weber, Congenital hypothyroidism with eutopic thyroid gland: analysis of clinical and biochemical features at diagnosis and after re-evaluation. J. Clin. Endocrinol. Metab. 98(4), 1395–1402 (2013). https://doi.org/10.1210/jc.2012-3174 CrossRefPubMed S. Rabbiosi, M.C. Vigone, F. Cortinovis, I. Zamproni, L. Fugazzola, L. Persani, C. Corbetta, G. Chiumello, G. Weber, Congenital hypothyroidism with eutopic thyroid gland: analysis of clinical and biochemical features at diagnosis and after re-evaluation. J. Clin. Endocrinol. Metab. 98(4), 1395–1402 (2013). https://​doi.​org/​10.​1210/​jc.​2012-3174 CrossRefPubMed
35.
40.
go back to reference P.E. Aleksander, M. Bruckner-Spieler, A.M. Stoehr, E. Lankes, P. Kuhnen, D. Schnabel, A. Ernert, W. Stablein, M.E. Craig, O. Blankenstein, A. Gruters, H. Krude, Mean high-dose l-thyroxine treatment is efficient and safe to achieve a normal iq in young adult patients with congenital hypothyroidism. J. Clin. Endocrinol. Metab. 103(4), 1459–1469 (2018). https://doi.org/10.1210/jc.2017-01937 CrossRefPubMed P.E. Aleksander, M. Bruckner-Spieler, A.M. Stoehr, E. Lankes, P. Kuhnen, D. Schnabel, A. Ernert, W. Stablein, M.E. Craig, O. Blankenstein, A. Gruters, H. Krude, Mean high-dose l-thyroxine treatment is efficient and safe to achieve a normal iq in young adult patients with congenital hypothyroidism. J. Clin. Endocrinol. Metab. 103(4), 1459–1469 (2018). https://​doi.​org/​10.​1210/​jc.​2017-01937 CrossRefPubMed
50.
go back to reference P. Vasudevan, C. Powell, A.K. Nicholas, I. Scudamore, J. Greening, S.M. Park, N. Schoenmakers, Intrauterine death following intraamniotic triiodothyronine and thyroxine therapy for fetal goitrous hypothyroidism associated with polyhydramnios and caused by a thyroglobulin mutation. Endocrinol. Diabetes Metab. Case Rep. 2017 (2017). https://doi.org/10.1530/EDM-17-0040 P. Vasudevan, C. Powell, A.K. Nicholas, I. Scudamore, J. Greening, S.M. Park, N. Schoenmakers, Intrauterine death following intraamniotic triiodothyronine and thyroxine therapy for fetal goitrous hypothyroidism associated with polyhydramnios and caused by a thyroglobulin mutation. Endocrinol. Diabetes Metab. Case Rep. 2017 (2017). https://​doi.​org/​10.​1530/​EDM-17-0040
53.
go back to reference L. Lichtenberger-Geslin, S. Dos Santos, Y. Hassani, E. Ecosse, T.Van Den Abbeele, J.Leger, Factors associated with hearing impairment in patients with congenital hypothyroidism treated since the neonatal period: a national population-based study. J. Clin. Endocrinol. Metab. 98(9), 3644–3652 (2013). https://doi.org/10.1210/jc.2013-1645 CrossRefPubMed L. Lichtenberger-Geslin, S. Dos Santos, Y. Hassani, E. Ecosse, T.Van Den Abbeele, J.Leger, Factors associated with hearing impairment in patients with congenital hypothyroidism treated since the neonatal period: a national population-based study. J. Clin. Endocrinol. Metab. 98(9), 3644–3652 (2013). https://​doi.​org/​10.​1210/​jc.​2013-1645 CrossRefPubMed
54.
go back to reference C.J. Eastman, M.B. Zimmermann, in The Iodine Deficiency Disorders. ed. by K.R. Feingold, B. Anawalt, A. Boyce, G. Chrousos, K. Dungan, A. Grossman, J.M. Hershman, G. Kaltsas, C. Koch, P. Kopp, M. Korbonits, R. McLachlan, J. E. Morley, M. New, L. Perreault, J. Purnell, R. Rebar, F. Singer, D.L. Trence, A. Vinik, D.P. Wilson (Endotext, South Dartmouth, MA, 2000) C.J. Eastman, M.B. Zimmermann, in The Iodine Deficiency Disorders. ed. by K.R. Feingold, B. Anawalt, A. Boyce, G. Chrousos, K. Dungan, A. Grossman, J.M. Hershman, G. Kaltsas, C. Koch, P. Kopp, M. Korbonits, R. McLachlan, J. E. Morley, M. New, L. Perreault, J. Purnell, R. Rebar, F. Singer, D.L. Trence, A. Vinik, D.P. Wilson (Endotext, South Dartmouth, MA, 2000)
55.
go back to reference M. Wasniewska, A. Corrias, M. Salerno, A. Mussa, D. Capalbo, M.F. Messina, T. Aversa, S. Bombaci, F. De Luca, M. Valenzise, Thyroid function patterns at Hashimoto’s thyroiditis presentation in childhood and adolescence are mainly conditioned by patients’ age. Horm. Res. Paediatr. 78(4), 232–236 (2012). https://doi.org/10.1159/000343815 CrossRefPubMed M. Wasniewska, A. Corrias, M. Salerno, A. Mussa, D. Capalbo, M.F. Messina, T. Aversa, S. Bombaci, F. De Luca, M. Valenzise, Thyroid function patterns at Hashimoto’s thyroiditis presentation in childhood and adolescence are mainly conditioned by patients’ age. Horm. Res. Paediatr. 78(4), 232–236 (2012). https://​doi.​org/​10.​1159/​000343815 CrossRefPubMed
58.
go back to reference J.L. Frias, M.L. Davenport, Health supervision for children with Turner syndrome. Pediatrics 111(3), 692–702 (2003)CrossRef J.L. Frias, M.L. Davenport, Health supervision for children with Turner syndrome. Pediatrics 111(3), 692–702 (2003)CrossRef
59.
60.
go back to reference E. Piatkowska, M. Szalecki, Autoimmune thyroiditis in children and adolescents with type 1 diabetes. Pediatr. Endocrinol., diabetes, Metab. 17(4), 173–177 (2011) E. Piatkowska, M. Szalecki, Autoimmune thyroiditis in children and adolescents with type 1 diabetes. Pediatr. Endocrinol., diabetes, Metab. 17(4), 173–177 (2011)
61.
go back to reference S. Severinski, S. Banac, N.S. Severinski, V. Ahel, K. Cvijovic, Epidemiology and clinical characteristics of thyroid dysfunction in children and adolescents with type 1 diabetes. Coll. Antropol. 33(1), 273–279 (2009)PubMed S. Severinski, S. Banac, N.S. Severinski, V. Ahel, K. Cvijovic, Epidemiology and clinical characteristics of thyroid dysfunction in children and adolescents with type 1 diabetes. Coll. Antropol. 33(1), 273–279 (2009)PubMed
68.
go back to reference M.C. Vigone, F. Cortinovis, S. Rabbiosi, M. Di Frenna, A. Passoni, L. Persani, G. Chiumello, C. Gelmetti, G. Weber, Difficult treatment of consumptive hypothyroidism in a child with massive parotid hemangioma. J. Pediatr. Endocrinol. Metab. 25(1-2), 153–155 (2012)CrossRef M.C. Vigone, F. Cortinovis, S. Rabbiosi, M. Di Frenna, A. Passoni, L. Persani, G. Chiumello, C. Gelmetti, G. Weber, Difficult treatment of consumptive hypothyroidism in a child with massive parotid hemangioma. J. Pediatr. Endocrinol. Metab. 25(1-2), 153–155 (2012)CrossRef
69.
go back to reference J. Jonklaas, A.C. Bianco, A.J. Bauer, K.D. Burman, A.R. Cappola, F.S. Celi, D.S. Cooper, B.W. Kim, R.P. Peeters, M.S. Rosenthal, A.M. Sawka, American Thyroid Association Task Force on Thyroid Hormone, R.: guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 24(12), 1670–1751 (2014). https://doi.org/10.1089/thy.2014.0028 CrossRefPubMedPubMedCentral J. Jonklaas, A.C. Bianco, A.J. Bauer, K.D. Burman, A.R. Cappola, F.S. Celi, D.S. Cooper, B.W. Kim, R.P. Peeters, M.S. Rosenthal, A.M. Sawka, American Thyroid Association Task Force on Thyroid Hormone, R.: guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 24(12), 1670–1751 (2014). https://​doi.​org/​10.​1089/​thy.​2014.​0028 CrossRefPubMedPubMedCentral
72.
go back to reference T.D. Nebesio, M.D. Wise, S.M. Perkins, E.A. Eugster, Does clinical management impact height potential in children with severe acquired hypothyroidism? J. Pediatr. Endocrinol. Metab. 24(11-12), 893–896 (2011)CrossRef T.D. Nebesio, M.D. Wise, S.M. Perkins, E.A. Eugster, Does clinical management impact height potential in children with severe acquired hypothyroidism? J. Pediatr. Endocrinol. Metab. 24(11-12), 893–896 (2011)CrossRef
73.
go back to reference J.B. Quintos, M. Salas, Use of growth hormone and gonadotropin releasing hormone agonist in addition to L-thyroxine to attain normal adult height in two patients with severe Hashimoto’s thyroiditis. J. Pediatr. Endocrinol. Metab. 18(5), 515–521 (2005)CrossRef J.B. Quintos, M. Salas, Use of growth hormone and gonadotropin releasing hormone agonist in addition to L-thyroxine to attain normal adult height in two patients with severe Hashimoto’s thyroiditis. J. Pediatr. Endocrinol. Metab. 18(5), 515–521 (2005)CrossRef
78.
go back to reference T. Aversa, A. Corrias, M. Salerno, D. Tessaris, R. Di Mase, M. Valenzise, D. Corica, F. De Luca, M. Wasniewska, Five-year prospective evaluation of thyroid function test evolution in children with hashimoto’s thyroiditis presenting with either euthyroidism or subclinical hypothyroidism. Thyroid. Assoc. 26(10), 1450–1456 (2016). https://doi.org/10.1089/thy.2016.0080 CrossRef T. Aversa, A. Corrias, M. Salerno, D. Tessaris, R. Di Mase, M. Valenzise, D. Corica, F. De Luca, M. Wasniewska, Five-year prospective evaluation of thyroid function test evolution in children with hashimoto’s thyroiditis presenting with either euthyroidism or subclinical hypothyroidism. Thyroid. Assoc. 26(10), 1450–1456 (2016). https://​doi.​org/​10.​1089/​thy.​2016.​0080 CrossRef
80.
go back to reference R.K. Marwaha, N. Tandon, R. Kanwar, M.A. Ganie, V. Bhattacharya, D.H. Reddy, S. Gopalakrishnan, R. Aggarwal, K. Grewal, S.K. Ganguly, K. Mani, Evaluation of the role of ultrasonography in diagnosis of autoimmune thyroiditis in goitrous children. Indian Pediatr. 45(4), 279–284 (2008)PubMed R.K. Marwaha, N. Tandon, R. Kanwar, M.A. Ganie, V. Bhattacharya, D.H. Reddy, S. Gopalakrishnan, R. Aggarwal, K. Grewal, S.K. Ganguly, K. Mani, Evaluation of the role of ultrasonography in diagnosis of autoimmune thyroiditis in goitrous children. Indian Pediatr. 45(4), 279–284 (2008)PubMed
81.
go back to reference M.S. Durmaz, N. Akyurek, T. Kara, F. Ates, B. Ozbakir, F. G. Durmaz, S. S. Karaagac, M. Ozturk, Quantitative assessment of thyroid gland vascularization with vascularization index using color superb microvascular imaging in pediatric patients with hashimoto thyroiditis. Ultrasound Q (2019). https://doi.org/10.1097/RUQ.0000000000000430 M.S. Durmaz, N. Akyurek, T. Kara, F. Ates, B. Ozbakir, F. G. Durmaz, S. S. Karaagac, M. Ozturk, Quantitative assessment of thyroid gland vascularization with vascularization index using color superb microvascular imaging in pediatric patients with hashimoto thyroiditis. Ultrasound Q (2019). https://​doi.​org/​10.​1097/​RUQ.​0000000000000430​
89.
go back to reference H. Gharib, R.M. Tuttle, H.J. Baskin, L.H. Fish, P.A. Singer, M.T. McDermott, Consensus statement #1: subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. Thyroid. 15(1), 24–28 (2005). https://doi.org/10.1089/thy.2005.15.24. response 32-23CrossRefPubMed H. Gharib, R.M. Tuttle, H.J. Baskin, L.H. Fish, P.A. Singer, M.T. McDermott, Consensus statement #1: subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. Thyroid. 15(1), 24–28 (2005). https://​doi.​org/​10.​1089/​thy.​2005.​15.​24. response 32-23CrossRefPubMed
92.
go back to reference M. Cerbone, C. Bravaccio, D. Capalbo, M. Polizzi, M. Wasniewska, D. Cioffi, N. Improda, M. Valenzise, D. Bruzzese, F. De Luca, M. Salerno, Linear growth and intellectual outcome in children with long-term idiopathic subclinical hypothyroidism. Eur. J. Endocrinol. 164(4), 591–597 (2011). https://doi.org/10.1530/EJE-10-0979 CrossRefPubMed M. Cerbone, C. Bravaccio, D. Capalbo, M. Polizzi, M. Wasniewska, D. Cioffi, N. Improda, M. Valenzise, D. Bruzzese, F. De Luca, M. Salerno, Linear growth and intellectual outcome in children with long-term idiopathic subclinical hypothyroidism. Eur. J. Endocrinol. 164(4), 591–597 (2011). https://​doi.​org/​10.​1530/​EJE-10-0979 CrossRefPubMed
95.
go back to reference K.D. Coyne, K.A. Trimble, A. Lloyd, L. Petrando, J. Pentz, K. Van Namen, A. Fawcett, C.M. Laing, Interventions to promote oral medication adherence in the pediatric chronic illness population: a systematic review from the Children’s Oncology Group. J. Pedia. Oncol. Nurs. 36(3), 219–235 (2019). https://doi.org/10.1177/1043454219835451 CrossRef K.D. Coyne, K.A. Trimble, A. Lloyd, L. Petrando, J. Pentz, K. Van Namen, A. Fawcett, C.M. Laing, Interventions to promote oral medication adherence in the pediatric chronic illness population: a systematic review from the Children’s Oncology Group. J. Pedia. Oncol. Nurs. 36(3), 219–235 (2019). https://​doi.​org/​10.​1177/​1043454219835451​ CrossRef
99.
go back to reference M.I. Liontiris, E.E. Mazokopakis, A concise review of Hashimoto thyroiditis (HT) and the importance of iodine, selenium, vitamin D and gluten on the autoimmunity and dietary management of HT patients.Points that need more investigation. Hell. J. Nucl. Med. 20(1), 51–56 (2017). https://doi.org/10.1967/s002449910507 CrossRefPubMed M.I. Liontiris, E.E. Mazokopakis, A concise review of Hashimoto thyroiditis (HT) and the importance of iodine, selenium, vitamin D and gluten on the autoimmunity and dietary management of HT patients.Points that need more investigation. Hell. J. Nucl. Med. 20(1), 51–56 (2017). https://​doi.​org/​10.​1967/​s002449910507 CrossRefPubMed
Metadata
Title
Thyroid hormone therapy in congenital hypothyroidism and pediatric hypothyroidism
Authors
Andrew J. Bauer
Ari J. Wassner
Publication date
01-10-2019
Publisher
Springer US
Published in
Endocrine / Issue 1/2019
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-02024-6

Other articles of this Issue 1/2019

Endocrine 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine